164 related articles for article (PubMed ID: 38878854)
1. Protein binder toolbox for studies of solute carrier transporters.
Gelová Z; Ingles-Prieto A; Bohstedt T; Frommelt F; Chi G; Chang YN; Garcia J; Wolf G; Azzollini L; Tremolada S; Scacioc A; Hansen JS; Serrano I; Droce A; Cuesta Bernal J; Burgess-Brown NA; Carpenter EP; Dürr KL; Kristensen P; Geertsma ER; Štefanić S; Scarabottolo L; Wiedmer T; Puetter V; Sauer DB; Superti-Furga G
J Mol Biol; 2024 Jun; ():168665. PubMed ID: 38878854
[TBL] [Abstract][Full Text] [Related]
2. The solute carrier transporters and the brain: Physiological and pharmacological implications.
Hu C; Tao L; Cao X; Chen L
Asian J Pharm Sci; 2020 Mar; 15(2):131-144. PubMed ID: 32373195
[TBL] [Abstract][Full Text] [Related]
3. Establishment of a novel microscale thermophoresis ligand-binding assay for characterization of SLC solute carriers using oligopeptide transporter PepT1 (SLC15 family) as a model system.
Clémençon B; Lüscher BP; Hediger MA
J Pharmacol Toxicol Methods; 2018; 92():67-76. PubMed ID: 29580877
[TBL] [Abstract][Full Text] [Related]
4. An Overview of Cell-Based Assay Platforms for the Solute Carrier Family of Transporters.
Dvorak V; Wiedmer T; Ingles-Prieto A; Altermatt P; Batoulis H; Bärenz F; Bender E; Digles D; Dürrenberger F; Heitman LH; IJzerman AP; Kell DB; Kickinger S; Körzö D; Leippe P; Licher T; Manolova V; Rizzetto R; Sassone F; Scarabottolo L; Schlessinger A; Schneider V; Sijben HJ; Steck AL; Sundström H; Tremolada S; Wilhelm M; Wright Muelas M; Zindel D; Steppan CM; Superti-Furga G
Front Pharmacol; 2021; 12():722889. PubMed ID: 34447313
[TBL] [Abstract][Full Text] [Related]
5. Structural biology of solute carrier (SLC) membrane transport proteins.
Bai X; Moraes TF; Reithmeier RAF
Mol Membr Biol; 2017; 34(1-2):1-32. PubMed ID: 29651895
[TBL] [Abstract][Full Text] [Related]
6. Targeting Solute Carrier Transporters (SLCs) as a Therapeutic Target in Different Cancers.
Bharadwaj R; Jaiswal S; Velarde de la Cruz EE; Thakare RP
Diseases; 2024 Mar; 12(3):. PubMed ID: 38534987
[TBL] [Abstract][Full Text] [Related]
7. Amino acid transporters within the solute carrier superfamily: Underappreciated proteins and novel opportunities for cancer therapy.
Hushmandi K; Einollahi B; Saadat SH; Lee EHC; Farani MR; Okina E; Huh YS; Nabavi N; Salimimoghadam S; Kumar AP
Mol Metab; 2024 Jun; 84():101952. PubMed ID: 38705513
[TBL] [Abstract][Full Text] [Related]
8. Structural and functional annotation of solute carrier transporters: implication for drug discovery.
Dvorak V; Superti-Furga G
Expert Opin Drug Discov; 2023; 18(10):1099-1115. PubMed ID: 37563933
[TBL] [Abstract][Full Text] [Related]
9. Computational Chemistry in Structure-Based Solute Carrier Transporter Drug Design: Recent Advances and Future Perspectives.
Tu G; Fu T; Zheng G; Xu B; Gou R; Luo D; Wang P; Xue W
J Chem Inf Model; 2024 Mar; 64(5):1433-1455. PubMed ID: 38294194
[TBL] [Abstract][Full Text] [Related]
10. A widespread role for SLC transmembrane transporters in resistance to cytotoxic drugs.
Girardi E; César-Razquin A; Lindinger S; Papakostas K; Konecka J; Hemmerich J; Kickinger S; Kartnig F; Gürtl B; Klavins K; Sedlyarov V; Ingles-Prieto A; Fiume G; Koren A; Lardeau CH; Kumaran Kandasamy R; Kubicek S; Ecker GF; Superti-Furga G
Nat Chem Biol; 2020 Apr; 16(4):469-478. PubMed ID: 32152546
[TBL] [Abstract][Full Text] [Related]
11. A phylogenetic analysis between humans and D. melanogaster: A repertoire of solute carriers in humans and flies.
Ceder MM; Fredriksson R
Gene; 2022 Jan; 809():146033. PubMed ID: 34673204
[TBL] [Abstract][Full Text] [Related]
12. Rational exploration of fold atlas for human solute carrier proteins.
Xie T; Chi X; Huang B; Ye F; Zhou Q; Huang J
Structure; 2022 Sep; 30(9):1321-1330.e5. PubMed ID: 35700727
[TBL] [Abstract][Full Text] [Related]
13. Solute Carrier Transporters as Potential Targets for the Treatment of Metabolic Disease.
Schumann T; König J; Henke C; Willmes DM; Bornstein SR; Jordan J; Fromm MF; Birkenfeld AL
Pharmacol Rev; 2020 Jan; 72(1):343-379. PubMed ID: 31882442
[TBL] [Abstract][Full Text] [Related]
14. Detection of Chemical Engagement of Solute Carrier Proteins by a Cellular Thermal Shift Assay.
Hashimoto M; Girardi E; Eichner R; Superti-Furga G
ACS Chem Biol; 2018 Jun; 13(6):1480-1486. PubMed ID: 29851333
[TBL] [Abstract][Full Text] [Related]
15. A substrate-based ontology for human solute carriers.
Meixner E; Goldmann U; Sedlyarov V; Scorzoni S; Rebsamen M; Girardi E; Superti-Furga G
Mol Syst Biol; 2020 Jul; 16(7):e9652. PubMed ID: 32697042
[TBL] [Abstract][Full Text] [Related]
16. Targeting SLC transporters: small molecules as modulators and therapeutic opportunities.
Schlessinger A; Zatorski N; Hutchinson K; Colas C
Trends Biochem Sci; 2023 Sep; 48(9):801-814. PubMed ID: 37355450
[TBL] [Abstract][Full Text] [Related]
17. Metabolic basis of solute carrier transporters in treatment of type 2 diabetes mellitus.
Le J; Chen Y; Yang W; Chen L; Ye J
Acta Pharm Sin B; 2024 Feb; 14(2):437-454. PubMed ID: 38322335
[TBL] [Abstract][Full Text] [Related]
18. The Identification and Evolutionary Trends of the Solute Carrier Superfamily in Arthropods.
Denecke SM; Driva O; Luong HNB; Ioannidis P; Linka M; Nauen R; Geibel S; Vontas J
Genome Biol Evol; 2020 Aug; 12(8):1429-1439. PubMed ID: 32681801
[TBL] [Abstract][Full Text] [Related]
19. Defining solute carrier transporter signatures of murine immune cell subsets.
Aaes TL; Burgoa Cardás J; Ravichandran KS
Front Immunol; 2023; 14():1276196. PubMed ID: 38077407
[TBL] [Abstract][Full Text] [Related]
20. An integrative in silico system for predicting dysregulated genes in the human epileptic focus: Application to SLC transporters.
Mirza N; Vasieva O; Appleton R; Burn S; Carr D; Crooks D; du Plessis D; Duncan R; Farah JO; Josan V; Miyajima F; Mohanraj R; Shukralla A; Sills GJ; Marson AG; Pirmohamed M
Epilepsia; 2016 Sep; 57(9):1467-74. PubMed ID: 27421837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
